Related Experiment Video
Updated: Apr 17, 2026
09:07
Murine Model of Epicutaneously-Induced Immunomodulation
Published on: June 24, 2025
650
Animal models for cutaneous vaccine delivery
Hoang J H B Hirschberg1, Elly van Riet1, Dinja Oosterhoff1
1Institute for Translational Vaccinology, P.O. Box 450, 3720 AL Bilthoven, The Netherlands.
Summary
Designing effective skin vaccination requires overcoming the skin barrier and targeting antigen-presenting cells (APCs). Understanding species-specific skin differences is crucial for translating animal study results to human clinical trials.
Area of Science:
- Dermatology
- Immunology
- Vaccinology
Background:
- Skin vaccination faces challenges with the stratum corneum (SC) barrier and targeting skin-resident antigen-presenting cells (APCs).
- Animal studies are essential for vaccine development but may not accurately predict human responses due to interspecies skin variations.
Purpose of the Study:
- To review critical variables in skin architecture and immunology for designing predictive animal models.
- To enhance the translation of skin vaccination strategies from animal studies to human clinical trials.
Main Methods:
- Review of literature on skin morphology, barrier function, mechanical properties, and immunology across species.
- Analysis of factors influencing skin vaccination efficacy and safety in preclinical models.
Main Results:
- Significant differences exist in skin structure and immune responses between animal models and humans.
- Skin barrier properties, mechanical characteristics, and immune cell distribution vary considerably by species and application site.
Conclusions:
- Careful consideration of species-specific skin characteristics is vital for successful animal study design in skin vaccination.
- Optimizing animal models based on comparative skin biology will improve the predictive value for human clinical outcomes.
